New heart valve device tested in humans for first time
Disease control
Recruiting now
This early study tests a new device called GEMINUS, which replaces a narrowed heart valve without open-heart surgery. It involves 30 people with severe aortic stenosis. The goal is to see if the procedure is safe and feasible, with follow-up for up to 5 years.
Phase: NA • Sponsor: Valve Medical • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC